Post-stroke øvre limb spasticity represents a significant challenge in motor recovery and the restoration of upper limb function, impacting daily activities. Multimodal treatment approaches are recommended for managing spasticity. Recent research has explored the potential of transcranial magnetic stimulation (TMS) to improve upper limb functions and reduce spasticity. However, the optimal TMS protocol when combined with botulinum toxin-A (BTX-A) remains unclear. The objective of this observational study was to compare the clinical effects of different TMS protocols in patients with post-stroke upper limb spasticity receiving BTX-A treatment and to determine the most appropriate TMS protocol. As part of the study, patients who received botulinum toxin type A (BTX-A) injections for upper extremity spasticity following stroke were evaluated using different TMS protocols. All patients received a standard conventional physical therapy program. TMS sessions were conducted using an inhibitory protocol, with a total of 10 sessions administered to the contralateral hemisphere at least 3 days per week. Clinical evaluations were performed at baseline, at 1 month, and at 3 months. Thus, the early and long-term clinical outcomes of treatment were investigated. Spasticity was assessed using the Modified Ashworth Scale (MAS), motor improvement using the Brunnstrom staging system, upper extremity motor function using the Fugl-Meyer Assessment, and upper extremity use in activities of daily living using the Motor Activity Log-28 (MAL-28). Additionally, patients' anxiety and depression levels were measured using the Hospital Anxiety and Depression Scale (HADS).